Practical application of 3-substituted-2,6-difluoropyridines in drug discovery: Facile synthesis of novel protein kinase C theta inhibitors

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2497-2501. doi: 10.1016/j.bmcl.2017.03.099. Epub 2017 Apr 2.

Abstract

We previously reported a facile preparation method of 3-substituted-2,6-difluoropyridines, which were easily converted to 2,3,6-trisubstituted pyridines by nucleophilic aromatic substitution with good regioselectivity and yield. In this study, we demonstrate the synthetic utility of 3-substituted-2,6-difluoropyridines in drug discovery via their application in the synthesis of various 2,3,6-trisubstituted pyridines, including macrocyclic derivatives, as novel protein kinase C theta inhibitors in a moderate to good yield. This synthetic approach is useful for the preparation of 2,3,6-trisubstituted pyridines, which are a popular scaffold for drug candidates and biologically attractive compounds.

Keywords: 2,3,6-Trisubstituted pyridine; 3-Substituted-2,6-difluoropyridine; Drug design; Macrocyclic derivatives; PKCθ inhibitor.

MeSH terms

  • Drug Design
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Isoenzymes / metabolism
  • Protein Kinase C / antagonists & inhibitors*
  • Protein Kinase C / metabolism
  • Protein Kinase C-theta
  • Protein Kinase Inhibitors / chemical synthesis*
  • Protein Kinase Inhibitors / chemistry
  • Pyridines / chemical synthesis
  • Pyridines / chemistry*

Substances

  • 2,6-difluoropyridine
  • Isoenzymes
  • Protein Kinase Inhibitors
  • Pyridines
  • PRKCQ protein, human
  • Protein Kinase C
  • Protein Kinase C-theta